• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活转录因子3干扰组蛋白去乙酰化酶抑制剂诱导的表皮样癌细胞生长抑制中p21的激活。

Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells.

作者信息

Hao Zhen-Feng, Su You-Ming, Wang Cong-min, Yang Rong-Ya

机构信息

Institute of Skin Damage and Repair, General Hospital of Beijing Region of PLA, Beijing, 100700, China.

出版信息

Tumour Biol. 2015 Mar;36(3):1471-6. doi: 10.1007/s13277-014-2618-1. Epub 2014 Nov 5.

DOI:10.1007/s13277-014-2618-1
PMID:25371069
Abstract

Inhibition of histone deacetylase (HDAC) activity by HDAC inhibitors (HDACis) results in cancer cell growth inhibition, and HDACis have been revealed as potential anti-skin cancer agents. p21 is a cyclin-dependent kinase inhibitor and an essential regulator of growth inhibition. Recently, we reported that activating transcription factor 3 (ATF3) could significantly promote skin cancer cell growth. This study explored the relationship between ATF3 and HDACi-induced growth inhibition of epidermoid carcinoma cells. We found that trichostatin A (TSA) treatment inhibited cell growth in A431 epidermoid carcinoma cells in a dose-dependent manner. Simultaneously, p21 and ATF3 expression levels were upregulated and downregulated upon TSA stimulation, respectively. ATF3 overexpression promoted cell growth and downregulated p21 expression. In contrast, ATF3 depletion resulted in cell growth reduction and p21 transcriptional upregulation. More importantly, ATF3 overexpression partially antagonized TSA-induced growth inhibition and p21 activation. Collectively, these data demonstrate that ATF3 acts as an essential negative regulator of TSA-induced cell growth inhibition through interfering with TSA-induced p21 activation.

摘要

组蛋白去乙酰化酶抑制剂(HDACis)对组蛋白去乙酰化酶(HDAC)活性的抑制作用会导致癌细胞生长受到抑制,并且HDACis已被证实是潜在的抗皮肤癌药物。p21是一种细胞周期蛋白依赖性激酶抑制剂,也是生长抑制的关键调节因子。最近,我们报道激活转录因子3(ATF3)可显著促进皮肤癌细胞的生长。本研究探讨了ATF3与HDACi诱导的表皮样癌细胞生长抑制之间的关系。我们发现曲古抑菌素A(TSA)处理以剂量依赖性方式抑制A431表皮样癌细胞的生长。同时,在TSA刺激后,p21和ATF3的表达水平分别上调和下调。ATF3过表达促进细胞生长并下调p21表达。相反,ATF3缺失导致细胞生长减少和p21转录上调。更重要的是,ATF3过表达部分拮抗TSA诱导的生长抑制和p21激活。总的来说,这些数据表明ATF3通过干扰TSA诱导的p21激活,作为TSA诱导的细胞生长抑制的重要负调节因子。

相似文献

1
Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells.激活转录因子3干扰组蛋白去乙酰化酶抑制剂诱导的表皮样癌细胞生长抑制中p21的激活。
Tumour Biol. 2015 Mar;36(3):1471-6. doi: 10.1007/s13277-014-2618-1. Epub 2014 Nov 5.
2
The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.组蛋白去乙酰化酶抑制剂帕比司他通过诱导细胞周期阻滞发挥对食管鳞癌细胞的抗癌作用。
Cell Biochem Funct. 2018 Dec;36(8):398-407. doi: 10.1002/cbf.3359. Epub 2018 Nov 28.
3
The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.组蛋白去乙酰化酶抑制剂曲古抑菌素A通过p21依赖性途径诱导细胞凋亡和细胞周期停滞,从而减少淋巴管生成。
BMC Cancer. 2016 Sep 30;16(1):763. doi: 10.1186/s12885-016-2807-y.
4
ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism.ERK 抑制通过 NF-κB 依赖和 Notch 非依赖的机制增强 TSA 诱导的胃癌细胞凋亡。
Life Sci. 2012 Sep 4;91(5-6):186-93. doi: 10.1016/j.lfs.2012.06.034. Epub 2012 Jul 7.
5
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.HeLa细胞中组蛋白去乙酰化酶抑制剂的HTP营养筛查以及曲古抑菌素A和葡萄籽(葡萄)中的组蛋白去乙酰化酶抑制剂对肿瘤抑制性微小RNA的影响
Cancer Genomics Proteomics. 2017 Jan 2;14(1):17-33. doi: 10.21873/cgp.20016.
6
P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.曲古抑菌素 A(TSA)对神经胶质瘤细胞中 P53 依赖性的抗增殖和促凋亡作用。
J Neurooncol. 2012 May;107(3):503-16. doi: 10.1007/s11060-011-0791-2. Epub 2012 Jan 20.
7
P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor.P21 驱动的多融合基因系统,通过体内分子成像评估组蛋白去乙酰化酶抑制剂的疗效,并通过组蛋白去乙酰化酶抑制剂介导的转录靶向治疗癌症。
J Nucl Med. 2014 Apr;55(4):678-85. doi: 10.2967/jnumed.113.126573. Epub 2014 Mar 17.
8
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).组蛋白去乙酰化酶抑制剂(曲古抑菌素A)与蛋白激酶C抑制剂(钙泊三醇)联合处理诱导肺癌和食管癌细胞凋亡
J Thorac Cardiovasc Surg. 2005 Jan;129(1):53-63. doi: 10.1016/j.jtcvs.2004.07.051.
9
Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.mTOR 信号抑制通过促进组蛋白乙酰化增强曲古抑菌素 A 对人胃癌细胞系的作用。
Cell Biol Int. 2014 Jan;38(1):50-63. doi: 10.1002/cbin.10179. Epub 2013 Oct 10.
10
Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3.不同的组蛋白去乙酰化酶调节人类细胞周期蛋白依赖性激酶抑制基因对曲古抑菌素A和1α,25-二羟基维生素D3的转录反应。
Nucleic Acids Res. 2008 Jan;36(1):121-32. doi: 10.1093/nar/gkm913. Epub 2007 Nov 13.

引用本文的文献

1
BM-MSCs alleviate diabetic nephropathy in male rats by regulating ER stress, oxidative stress, inflammation, and apoptotic pathways.骨髓间充质干细胞通过调节内质网应激、氧化应激、炎症和凋亡途径减轻雄性大鼠的糖尿病肾病。
Front Pharmacol. 2023 Nov 16;14:1265230. doi: 10.3389/fphar.2023.1265230. eCollection 2023.
2
Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells.氟伐他汀和洛伐他汀对人宫颈癌 HeLa 细胞中 p21 诱导的调控机制。
PLoS One. 2019 Apr 2;14(4):e0214408. doi: 10.1371/journal.pone.0214408. eCollection 2019.

本文引用的文献

1
ATF3 activates Stat3 phosphorylation through inhibition of p53 expression in skin cancer cells.ATF3通过抑制皮肤癌细胞中p53的表达来激活Stat3磷酸化。
Asian Pac J Cancer Prev. 2013;14(12):7439-44. doi: 10.7314/apjcp.2013.14.12.7439.
2
The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter.bZIP阻遏蛋白、c-Jun二聚化蛋白2和激活转录因子3将多个组蛋白去乙酰化酶成员招募至ATF3启动子。
Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1142-53. doi: 10.1016/j.bbagrm.2012.09.005. Epub 2012 Sep 16.
3
3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.
3,3'-二吲哚甲烷通过 ATF4 诱导人结直肠癌细胞中的激活转录因子 3(ATF3)。
J Nutr Biochem. 2013 Apr;24(4):664-71. doi: 10.1016/j.jnutbio.2012.03.016. Epub 2012 Jul 21.
4
The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms.ATF3在鉴别皮肤鳞状细胞癌与其他皮肤上皮性肿瘤中的作用。
J Cutan Pathol. 2012 Aug;39(8):762-8. doi: 10.1111/j.1600-0560.2012.01938.x. Epub 2012 Jul 5.
5
The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.应激反应介质 ATF3 通过与雄激素受体结合来抑制雄激素信号。
Mol Cell Biol. 2012 Aug;32(16):3190-202. doi: 10.1128/MCB.00159-12. Epub 2012 Jun 4.
6
ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation.ATF3 通过抑制 25-羟胆固醇诱导的脂滴形成来防止动脉粥样硬化。
J Exp Med. 2012 Apr 9;209(4):807-17. doi: 10.1084/jem.20111202. Epub 2012 Apr 2.
7
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells.关键作用的 ATF3 在 p53 依赖的 DR5 诱导 DNA 损伤后人类结肠癌细胞。
Oncogene. 2012 Apr 26;31(17):2210-21. doi: 10.1038/onc.2011.397. Epub 2011 Sep 19.
8
Opposing roles for calcineurin and ATF3 in squamous skin cancer.钙调神经磷酸酶和活化转录因子3在鳞状皮肤癌中的相反作用。
Nature. 2010 May 20;465(7296):368-72. doi: 10.1038/nature08996.
9
Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.组蛋白去乙酰化酶抑制剂诱导结肠癌细胞凋亡的敏感性是由 Sp1/Sp3 激活的涉及即刻早期基因诱导的转录程序介导的。
Cancer Res. 2010 Jan 15;70(2):609-20. doi: 10.1158/0008-5472.CAN-09-2327. Epub 2010 Jan 12.
10
Histone deacetylase inhibitors in cancer therapy.组蛋白去乙酰化酶抑制剂在癌症治疗中的应用。
J Clin Oncol. 2009 Nov 10;27(32):5459-68. doi: 10.1200/JCO.2009.22.1291. Epub 2009 Oct 13.